Carri Geer

Carri Geer, PhD, leads drug substance, drug product, device and analytical development for Novan’s drug candidates. Additionally, Dr. Geer serves as the technical liaison for collaborative partnerships. Dr. Geer has more than 10 years of experience in pharmaceutical product development, and a background in analytical and bioanalytical chemistry. During her tenure at Novan, Dr. Geer has been responsible for establishing and growing the analytical capabilities of the company. Prior to joining Novan, Dr. Geer was employed at Merck and bridged the interface between R&D and cGMP analytical testing. Dr. Geer received her Ph.D. in Chemistry from the University of North Carolina at Chapel Hill.